Roche's strong U.S. presence and diversified product portfolio may mitigate the impact of potential tariffs, making it a ...

The popular diet and health company has been around for more than six decades but is struggling in the face of stiff ...

Karen Coe, 59, who has type 2 diabetes, says she was prescribed a GLP-1 medication to help her lose weight and get her ...

As obesity rates rise among individuals with T1D, GLP-1 agonist medications, indicated for T2D and weight loss, are ...

A decision by CMS to not move forward with a proposed rule allowing obesity medications to be covered under Medicare Part D ...

Employer health plans brace for ongoing soaring costs as weight-loss drug utilization rises. What trends are coming down the ...

Denmark’s economy was reshaped by Novo Nordisk and obesity drugs. That identity is now under attack on multiple fronts, from ...

Danish pharmaceutical company Novo Nordisk — best known for its blockbuster weight-loss drugs Ozempic and Wegovy — has signed ...

Hello, it’s Sonja in Frankfurt, bringing back insights from a trip to the German town of Ingelheim about an emerging ...